Literature DB >> 26601966

Computer Aided Drug Design: Success and Limitations.

Mohammad Hassan Baig1, Khurshid Ahmad, Sudeep Roy, Jalaluddin Mohammad Ashraf, Mohd Adil, Mohammad Haris Siddiqui, Saif Khan, Mohammad Amjad Kamal, Ivo Provazník, Inho Choi2.   

Abstract

Over the last few decades, computer-aided drug design has emerged as a powerful technique playing a crucial role in the development of new drug molecules. Structure-based drug design and ligand-based drug design are two methods commonly used in computer-aided drug design. In this article, we discuss the theory behind both methods, as well as their successful applications and limitations. To accomplish this, we reviewed structure based and ligand based virtual screening processes. Molecular dynamics simulation, which has become one of the most influential tool for prediction of the conformation of small molecules and changes in their conformation within the biological target, has also been taken into account. Finally, we discuss the principles and concepts of molecular docking, pharmacophores and other methods used in computer-aided drug design.

Mesh:

Substances:

Year:  2016        PMID: 26601966     DOI: 10.2174/1381612822666151125000550

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  55 in total

1.  Molecular modeling and LC-MS-based metabolomics of a glutamine-valproic acid (Gln-VPA) derivative on HeLa cells.

Authors:  M J Fragoso-Vázquez; D Méndez-Luna; M C Rosales-Hernández; G R Luna-Palencia; A Estrada-Pérez; Benedicte Fromager; I Vásquez-Moctezuma; J Correa-Basurto
Journal:  Mol Divers       Date:  2020-04-24       Impact factor: 2.943

2.  A computational approach yields selective inhibitors of human excitatory amino acid transporter 2 (EAAT2).

Authors:  Kelly L Damm-Ganamet; Marie-Laure Rives; Alan D Wickenden; Heather M McAllister; Taraneh Mirzadegan
Journal:  J Biol Chem       Date:  2020-02-20       Impact factor: 5.157

3.  Elucidation of marine fungi derived anthraquinones as mycobacterial mycolic acid synthesis inhibitors: an in silico approach.

Authors:  Akanksha Sharma; M Hayatul Islam; Nida Fatima; Tarun K Upadhyay; M Kalim A Khan; Upendra N Dwivedi; Rolee Sharma
Journal:  Mol Biol Rep       Date:  2019-02-04       Impact factor: 2.316

4.  Editorial: Frontier Views in Designing Therapeutic Candidates for Management of Diverse Diseases.

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

5.  Alisertib induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt/mTOR- and p38 MAPK-mediated pathways in human glioblastoma cells.

Authors:  Zheng Liu; Feng Wang; Zhi-Wei Zhou; He-Chun Xia; Xin-Yu Wang; Yin-Xue Yang; Zhi-Xu He; Tao Sun; Shu-Feng Zhou
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

6.  Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part C)).

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 7.  Modulation of DNA structure formation using small molecules.

Authors:  Imee M A Del Mundo; Karen M Vasquez; Guliang Wang
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-09-03       Impact factor: 4.739

8.  CDOCKER and λ-dynamics for prospective prediction in D₃R Grand Challenge 2.

Authors:  Xinqiang Ding; Ryan L Hayes; Jonah Z Vilseck; Murchtricia K Charles; Charles L Brooks
Journal:  J Comput Aided Mol Des       Date:  2017-09-07       Impact factor: 3.686

9.  Editorial: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development.

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 10.  Rethinking drug design in the artificial intelligence era.

Authors:  Petra Schneider; W Patrick Walters; Alleyn T Plowright; Norman Sieroka; Jennifer Listgarten; Robert A Goodnow; Jasmin Fisher; Johanna M Jansen; José S Duca; Thomas S Rush; Matthias Zentgraf; John Edward Hill; Elizabeth Krutoholow; Matthias Kohler; Jeff Blaney; Kimito Funatsu; Chris Luebkemann; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2019-12-04       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.